期刊文献+

血清糖类抗原及癌胚抗原联合检测在肺癌诊断中的意义 被引量:6

Significance of combined detection of carbohydrate antigen and carcinoembryonic antigen in diagnosing lung cancer
暂未订购
导出
摘要 目的评价联合检测血清糖类抗原CA199、CA125、CA153及癌胚抗原(CEA)4项指标对肺癌的诊断价值。方法选取53例肺癌患者作为肺癌组,48例同期住院的良性肺疾病患者作为良性肺疾病组,50例同期体检合格的健康成人作为健康对照组,采用化学发光免疫分析法检测3组入选对象的CA199、CA125、CA153、CEA血清水平并进行对比。结果肺癌患者血清CA199、CA125、CA153、CEA值均明显高于健康对照组及良性肺疾病组,差异均有统计学意义(P<0.05);CA199、CA125、CA153、CEA 4项指标联合检测的敏感性(75.84%)和较单项指标检测敏感性(CA199为23.12%,CA125为38.45%,CA153为21.33%,CEA为35.11%)均有提高,差异均有统计学意义(P<0.05)。结论联合检测血清CA199、CA125、CA153及CEA能提高对肺癌的阳性检出率,临床诊断价值更大。 Objective To investigate the diagnostic value of combined detection of four tumor markers carbohydrate antigen CA199,CA125,CA153 and carcinoembryonic antigen(CEA) in lung cancer.Methods Serum levels of CA199,CA125,CA153 and CEA in 53 cases of lung cancer,48 cases of benign lung lesions and 50 normal controls were detected by chemiluminescence immunoassay.Results Serum CA199,CA125,CA153 and CEA levels in lung cancer patients were significantly higher than those in normal controls and benign lung lesions patients with statisticaldifference(P0.05).The sensitivity for diagnosing lung cancer in the combination detection of serum CA199,CA125,CA153 and CEA were 75.84%.The sensitivity in single detection were 23.12% for CA199,38.45% for CA125,21.33% for CA153,and 35.11% for CEA.The sensitivity in the combination detection were increased compared with detection of single index,showing statistical difference(P0.05).Conclusion Combined determination of serum CA199,CA125,CA153 and CEA can improve the sensitivity and specificity in the diagnosis and differential diagnosis of lung cancer.
作者 鲁礴 杨玉梅
出处 《检验医学与临床》 CAS 2012年第2期172-173,176,共3页 Laboratory Medicine and Clinic
关键词 糖类抗原 肺癌 癌胚抗原 carbohydrate antigen lung cancer carcinoembryonic antigen
  • 相关文献

参考文献8

  • 1Kasprzak A,Zabel M,Biczysko W.Selected markers(ehromograninA,neuron-specific enolase,synaptophysin,protein gene product 9.5)in diagnosis and prognosis of neuroendocrine pulmonary tumour[J].Pol J Pathol,2007,58(1):23-33.
  • 2Spira A,Ettinger DS.Multidisciplinary management of lung cancer[J].N Engl Med,2004,350(4):379-392.
  • 3Molina R,Auge JM,Bosch X,et al.Usefulness of serum tumor markers,including progastrin-releasing peptide,in patients with lung cancer:correlation with histology[J].Tumor Biol,2009,30(3):121-129.
  • 4Gaida FJ,Pieper D,Roder UW,et al.Molecular characterization of a cloned idiotypic cascade containing a network antigenic determinant specific for the human carcinoembryonic antigen[J].J Biol Chem,1993,268(19):14138-14145.
  • 5Turbide C,Rojas M,Stanners CP,et al.A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule[J].J Biol Chem,1991,266(1):309-315.
  • 6Nawata S,Sugino N,Kato H.Squamous cell carcinoma antigen[J].Nippon Rinsho,2005,63(Suppl 8):684-686.
  • 7Cho WC.Potentially useful biomarkers for the diagnosis,treatment and prognosis of lung cancer[J].Biomed Pharmacother,2007,61(9):515-519.
  • 8Ren YR,Patel K,Paun BC,et al.Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers[J].Biol Chem,2011,286(14):11960-11969.

同被引文献46

  • 1姜晓明,陈爽,杜晓艳,鞠晓红.5种血清肿瘤标志物检测在肺癌诊断中的临床价值[J].吉林医药学院学报,2013,34(2):81-84. 被引量:28
  • 2刘解生,陈桂申.肺癌患者血清C―反应蛋白检测意义探讨[J].中国医学工程,2011,19(3). 被引量:2
  • 3王佳,王东,向德兵,李增鹏,马俊刚,王阁.C-12多肿瘤标志物蛋白质芯片检测系统对肺癌诊断的临床价值[J].解放军医学杂志,2006,31(4):349-350. 被引量:13
  • 4万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 5Kasprzak A,Zabel M,Biczsko W.Selected markers ( ehromograninA, nenuron-specific enolase, synapotophysin,proten gene product 9.5 )in diagnosis andprognosis of neuroendocrine pulmonary tumour[J].Pol J Pathol,2007,58 ( 1 ):23-33.
  • 6Comharet V,Bergeron C, Brjon S,et al.Protein chiparray profiling analysis ofsera from neuroblastoma patients[J].Cancer Lett, 2005,228 ( 1 ): 91.
  • 7Yip TT,Cho WC,Cheng WW,et al. Application of proteinohip array profilingin serum biomarker discovery for patients suffering feom secere acuterespiratory syndrome[J].Methods Mol Biol, 2007,382 (20): 313.
  • 8Curran WJ, Scott CB, Langer JL, et al. Long-term benefit is ob- served in a phase II comparison of sequential vs. concurrent chemoradiation therapy for patients with unresectable stage 1[ NSCLC [ J ]. Proc Am Soc Clin Oncol, 2003, 22 (10) : 621.
  • 9Kasprzak A, Zabel M, Biezsko W. Selected markers( ehromogra- ninA, nenuron-specific enolase, synapotophysin, proten gene product 9.5 ) in diagnosis and prognosis of neuroendocrine pul- monary tumour[J]. Pol J Pathol, 2007, 58 (1) : 23 -33.
  • 10Tomita M, Shimizu T, Ayabe T, et al. Carcinoembryonic antigen level in serum and pleural lavage fluid in non-small cell lung cancer[ J]. Thorac Cardiovasc Surg, 2010, 58 (6) : 350 - 353.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部